Andrea Cercek, MD (IMAGE)
Caption
Andrea Cercek, MD, was part of the team, with Luis Diaz Jr., MD, at Memorial Sloan Kettering Cancer Center, that demonstrates how immunotherapy alone can help patients with MMRd cancers avoid surgery and preserve their quality of life. The results, presented simultaneously at the 2025 American Association of Cancer Research (AACR) Annual Meeting and The New England Journal of Medicine, showed that 80% of patients with several types of cancer treated with immunotherapy did not require surgery, radiation, or chemotherapy after six months of treatment with immunotherapy alone. Swim Across America awarded grants for the early-stage research and continues to award grants for the ongoing clinical trial.
Credit
Memorial Sloan Kettering
Usage Restrictions
None
License
Original content